LiX,LewisMT,HuangJ,GutierrezC,OsborneCK,WuMF, 2008.Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy,J Nati Cancer Inst 100 672 -9
GoswamiS,WangW,WyckoffJB,CondeelisJS, 2004.Breast cancer cells isolated by chemotaxis from primary tumors show increased survival and resistance to chemotherapy,Cancer Res 64 7664 -7
SteinerR,StewartJF,CantwellBM,MintonMJ,KnightRK,RubensRD, 1983.Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer,Eur J Cancer Clin Oncol 19 1553 -7
MaF,ZhangJ,ZhongL,WangL,LiuY,WangY, 2013.Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/-catenin signaling,Gene 535 191 -7
LeeJM,DedharS,KalluriR,ThompsonEW, 2006.The epithelialmesenchymal transition: new insights in signaling, development, and disease,J Cell Biol 172 973 -81
PeinadoH,OlmedaD,CanoA, 2007.Snail, ZEB and BHLH factors in tumour progression: an alliance against the epithelial phenotype,Nat Rev Cancer 7 415 -28
Chavez-MacGregorM,Gonzalez-AnguloAM, 2013.Breast cancer in 2012: New drugs, new knowledge, new targets,Nat Rev Clin Oncol 10 75 -6
ZardavasD,BaselgaJ,PiccartM., 2013.Emerging targeted agents in metastatic breast cancer,Nat Rev Clin Oncol 10 191 -210
ShenH,WangD,LiL,YangS,ChenX,ZhouS, 2016.-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway,Gene 596 110 -8
NooterK,StoterG, 1996.Molecular mechanisms of multidrug resistance in cancer chemotherapy,Pathol Res Pract 192 768 -80
BurgerH,FoekensJA,LookMP,MeijervanMG,KlijnJG,WiemerEA, 2003.RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistanceassociated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response,Clin Cancer Res 9 827 -36
ColeyHM, 2008.Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer,Cancer Treat Rev 34 378 -90
MccubreyJA,AbramsSL,FitzgeraldTL,CoccoL,MartelliAM,MontaltoG, 2015.Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis,Adv Biol Regul 57 75 -101
de HerrerosAG,PeiróS,NassourM,SavagnerP, 2010.Snail family regulation and epithelial mesenchymal transitions in breast cancer progression,J Mammary Gland Biol Neoplasia 15 135 -47
ZhangA,WangQ,HanZ,WeiHU,LingXI,GaoQ, 2013.Reduced expression of snail decreases breast cancer cell motility by downregulating the expression and inhibiting the activity of RhoA GTPase,Oncol Lett 6 339 -46
TsubakiM,KomaiM,FujimotoSI,ItohT,ImanoM,SakamotoK, 2013.Activation of NF-B by the RANKL/RANK system upregulates snail and twist expressions and induces epithelial-tomesenchymal transition in mammary tumor cell lines,J Exp Clin Cancer Res 32 62 -
BrabantG,Hoang-VuC,CetinY,DralleH,ScheumannG,MölneJ, 1993.E-cadherin: a differentiation marker in thyroid malignancies,Cancer Res 53 4987 -93
KremerM,Quintanilla-MartinezL,FuchsM,GamboaDominguezA,HayeS,KalthoffH, 2003.Influence of tumorassociated e-cadherin mutations on tumorigenicity and metastasis,Carcinogenesis 24 1879 -86
MatsumotoK,ShariatSF,CasellaR,WheelerTM,SlawinKM,LernerSP, 2003.Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy,J Urol 170 2248 -52
ZhuoWL,WangY,ZhuoXL,ZhangYS,ChenZT, 2008.Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/ mitochondrial pathway,Biochem Biophys Res Commun 369 1098 -102